Hegseth's plan to screen military members for low testosterone raises concern for doctors: "Not a performance drug"

Defense Secretary Pete Hegseth recently announced a new policy requiring annual testosterone deficiency screenings for all U.S. service members over the age of 30. Under this plan, troops identified with low levels would have the option to pursue testosterone replacement therapy as part of their health assessments. The stated goal is to ensure personnel maintain levels that allow them to function at their best capacity.

Medical experts are questioning the scientific basis and the financial impact of this initiative. National organizations such as the Endocrine Society and the American College of Physicians currently advise against general screenings for testosterone. Doctors note that hormone levels naturally fluctuate based on sleep, stress, and time of day, making universal testing complex and prone to inaccurate results. A single test is rarely sufficient for a clinical diagnosis, as medical standards require multiple assessments conducted within a specific morning window.

Beyond the logistical challenges, clinicians warn of potential health risks associated with unnecessary hormone therapy. Treatment can lead to increased red blood cell production, which carries a risk of blood clots, pulmonary embolisms, and potential fertility issues. Experts emphasize that testosterone is not a performance-enhancing drug and that simply raising a numerical value does not inherently improve combat readiness or physical capability.

The cost of implementing this program is expected to be significant. Conservative estimates suggest that mandatory blood draws for the entire force over 30 will require millions of dollars in funding, not including the expenses for follow-up testing and monitoring. Critics argue that these resources would be more effective if directed toward addressing the underlying causes of fatigue or stress, such as poor sleep and operational pressure.

This move aligns with a broader trend of wellness initiatives focused on body modification, yet many physicians maintain that the current military proposal lacks evidence of clinical benefit. Without clear data showing that this screening improves performance or health, the medical community remains concerned that the policy will lead to widespread over-diagnosis and avoidable medical risks for those currently serving.